Fact sheet: Polar Capital Healthcare Opp

Fund information

Fund name
Polar Capital Healthcare Opportunities I GBP
Fund company manager
Polar Capital
Fund type
SIB
Fund manager(s)
Daniel Mahony
since 30/11/2007
Gareth Powell
since 30/11/2007
Fund objective
The Fund aims to preserve capital and achieve long-term growth by investing in a globally-diversified portfolio of companies within the healthcare industry.
Benchmark
MSCI ACWI Health Care Index
Investment style
Active,Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

10.71 %

1 Year rank in sector

19/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.5 b

FE Risk score

146

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    70.12%
  • UK
    10.17%
  • Money Market
    4.18%
  • France
    3.62%
  • Germany
    3.59%
  • Biotechnology/Medical
    30.1%
  • Pharmaceuticals
    29.8%
  • Health Care
    18.39%
  • Healthcare & Medical Products
    17.53%
  • Money Market
    4.18%
  • US Equities
    70.1%
  • UK Equities
    10.2%
  • Money Market
    4.2%
  • French Equities
    3.6%
  • German Equities
    3.6%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund4.21 %7.8 %10.71 %58.28 %183.91 %
Sector1.18 %8.1 %14.79 %27.68 %100.39 %
Rank within sector4 / 3118 / 3119 / 304 / 281 / 24
Quartile th1 st3 rd3 rd1 st1 st

Calendar performance

YTD-20172016201520142013
Fund16.7 %4.59 %13.39 %34.81 %52.86 %
Sector17.13 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector17 / 305 / 308 / 2812 / 257 / 24
Quartile th3 rd1 st2 nd2 nd2 nd

Risk statistics

Alpha10
Beta0.7
Sharpe0.76
Volatility15.04
Tracking error11.57
Information ratio0.65
R-Squared0.52

Price movement

52 week high32.74
52 week low26.5
Current bid price0
Current offer price0
Current mid price31.94

Holdings by region

  • 70.12% USA
  • 10.17% UK
  • 4.18% Money Market
  • 3.62% France
  • 3.59% Germany
  • 3.29% Denmark
  • 3.09% Ireland
  • 1.22% Sweden
  • 0.71% Canada

Holdings by sector

  • 30.1% Biotechnology/Medical
  • 29.8% Pharmaceuticals
  • 18.39% Health Care
  • 17.53% Healthcare & Medical Products
  • 4.18% Money Market

Holdings by asset type

  • 70.1% US Equities
  • 10.2% UK Equities
  • 4.2% Money Market
  • 3.6% French Equities
  • 3.6% German Equities
  • 3.3% Danish Equities
  • 3.1% Irish Equities
  • 1.2% Swedish Equities
  • 0.7% Canadian Equities

Individual holdings

  • 8.84% JOHNSON & JOHNSON
  • 4.58% ABBOTT LABORATORIES
  • 4.24% CELGENE CORP
  • 4.02% GLAXOSMITHKLINE
  • 3.71% UNITEDHEALTH GROUP INC
  • 3.62% SANOFI
  • 3.59% FRESENIUS SE & CO KGAA
  • 3.29% GENMAB AS
  • 3.18% BRISTOL-MYERS SQUIBB CO
  • 3.09% ALEXION PHARMACEUTICALS INC